ID: ALA3287834

Max Phase: Preclinical

Molecular Formula: C21H20N2OS

Molecular Weight: 348.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(NC(=N)c2ccccc2)cc1CSc1ccccc1

Standard InChI:  InChI=1S/C21H20N2OS/c1-24-20-13-12-18(23-21(22)16-8-4-2-5-9-16)14-17(20)15-25-19-10-6-3-7-11-19/h2-14H,15H2,1H3,(H2,22,23)

Standard InChI Key:  JUHJTTYKTBJFHZ-UHFFFAOYSA-N

Associated Targets(Human)

Pyroglutamylated RFamide peptide receptor 276 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 348.47Molecular Weight (Monoisotopic): 348.1296AlogP: 5.42#Rotatable Bonds: 6
Polar Surface Area: 45.11Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.79CX LogP: 5.17CX LogD: 3.80
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.35Np Likeness Score: -0.93

References

1. Nordqvist A, Kristensson L, Johansson KE, Isaksson da Silva K, Fex T, Tyrchan C, Svensson Henriksson A, Nilsson K..  (2014)  New Hits as Antagonists of GPR103 Identified by HTS.,  (5): [PMID:24900874] [10.1021/ml400519h]

Source